BioCentury | Dec 6, 2010
Company News

Collegium dermatology news

...Collegium spun out its Onset Therapeutics LLC subsidiary into newco Precision Dermatology Inc. (Cumberland, R.I.), which will...
BioCentury | Nov 15, 2010
Company News

Onset Therapeutics, Oculus sales and marketing update

...Oculus has commercialized two Microcyn-based dermatology products in the U.S. Further terms were not disclosed. Onset Therapeutics...
BioCentury | Jun 14, 2010
Company News

Onset Therapeutics dermatology news

...for acne and Hylatopic Emollient Foam for various dermatoses. The products were launched in 2H09. Onset Therapeutics...
BioCentury | Jul 21, 2008
Company News

Collegium inflammation news

...develops and markets its wound care and dermatology products using DELEVO foam technology through its Onset Therapeutics...
BioCentury | Dec 10, 2007
Clinical News

Topical genital warts agent regulatory update

...Collegium's Onset Therapeutics unit submitted a marketing application to FDA for an undisclosed topical agent to treat...
BioCentury | Jun 19, 2006
Regulation

Reformulating IP plans

...and narrower claims." ALXA (Palo Alto, Calif.) uses its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Mar 9, 2006
Financial News

Alexza prices IPO

...to $86.3 million in December. ALXA is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Feb 16, 2006
Financial News

Alexza amends IPO

...raise up to $86.3 million. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Jan 2, 2006
Finance

Ebb & Flow

...Pacific Growth; RBC; and JMP. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Dec 23, 2005
Financial News

Alexza files for IPO

...Capital Markets; and JMP Securities. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
Items per page:
1 - 10 of 11
BioCentury | Dec 6, 2010
Company News

Collegium dermatology news

...Collegium spun out its Onset Therapeutics LLC subsidiary into newco Precision Dermatology Inc. (Cumberland, R.I.), which will...
BioCentury | Nov 15, 2010
Company News

Onset Therapeutics, Oculus sales and marketing update

...Oculus has commercialized two Microcyn-based dermatology products in the U.S. Further terms were not disclosed. Onset Therapeutics...
BioCentury | Jun 14, 2010
Company News

Onset Therapeutics dermatology news

...for acne and Hylatopic Emollient Foam for various dermatoses. The products were launched in 2H09. Onset Therapeutics...
BioCentury | Jul 21, 2008
Company News

Collegium inflammation news

...develops and markets its wound care and dermatology products using DELEVO foam technology through its Onset Therapeutics...
BioCentury | Dec 10, 2007
Clinical News

Topical genital warts agent regulatory update

...Collegium's Onset Therapeutics unit submitted a marketing application to FDA for an undisclosed topical agent to treat...
BioCentury | Jun 19, 2006
Regulation

Reformulating IP plans

...and narrower claims." ALXA (Palo Alto, Calif.) uses its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Mar 9, 2006
Financial News

Alexza prices IPO

...to $86.3 million in December. ALXA is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Feb 16, 2006
Financial News

Alexza amends IPO

...raise up to $86.3 million. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Jan 2, 2006
Finance

Ebb & Flow

...Pacific Growth; RBC; and JMP. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
BioCentury | Dec 23, 2005
Financial News

Alexza files for IPO

...Capital Markets; and JMP Securities. Alexza is using its Staccato delivery platform to develop rapid onset therapeutics...
Items per page:
1 - 10 of 11